Weixiang Lu
Impact in
- Oncology top 1%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Lung Cancer Diagnosis and Treatment 3
- Ferroptosis and cancer prognosis 2
- Sarcoma Diagnosis and Treatment 1
- Respiratory Support and Mechanisms 1
- Oncology 5
- Co-authors
- Jianxing He (6 shared papers)Wenhua Liang (4 shared papers)Jianfu Li (4 shared papers)Caichen Li (3 shared papers)Ke Xu (2 shared papers)Hengrui Liang (3 shared papers)Ruchong Chen (1 shared paper)Wei Wang (1 shared paper)
- Journals
- Annals of Hematology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Advanced Science (1 paper)Frontiers in Neurorobotics (1 paper)Blood Cells Molecules and Diseases (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weixiang Lu
17 papers receiving 2.9k citations
Weixiang Lu's Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 2.0k
- Infectious Diseases 919
- Neurology 172
- Radiology, Nuclear Medicine and Imaging 246
- Obstetrics and Gynecology 75
Countries citing papers authored by Weixiang Lu
This map shows the geographic impact of Weixiang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixiang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixiang Lu more than expected).
Fields of papers citing papers by Weixiang Lu
This network shows the impact of papers produced by Weixiang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixiang Lu. The network helps show where Weixiang Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weixiang Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Hit paper breakdown → | 2020 | 2890 |
| 2 | 2021 | 43 | |
| 3 | 2021 | 9 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 5 | |
| 7 | 2021 | 5 | |
| 8 | 2025 | 4 | |
| 9 | 2021 | 4 | |
| 10 | 2022 | 4 | |
| 11 | 2024 | 3 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2023 | 0 | |
| 20 | 2025 | 0 |
About Weixiang Lu
Weixiang Lu is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 20 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (3 papers), Ferroptosis and cancer prognosis (2 papers), Acute Myeloid Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Respiratory Support and Mechanisms (1 paper) and Surface Roughness and Optical Measurements (1 paper). The work is most often cited by research in Oncology (2.0k citations), Infectious Diseases (919 citations), Neurology (172 citations), Radiology, Nuclear Medicine and Imaging (246 citations) and Obstetrics and Gynecology (75 citations). Weixiang Lu has collaborated with scholars based in China and United States. Frequent co-authors include Jianxing He, Wenhua Liang, Jianfu Li, Caichen Li, Ke Xu, Hengrui Liang, Ruchong Chen, Wei Wang, Wei‐jie Guan and Shiyue Li. Their work appears in journals such as Annals of Hematology, Journal for ImmunoTherapy of Cancer, Advanced Science, Frontiers in Neurorobotics and Blood Cells Molecules and Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.